Compare Hyperliquid Strategies Inc Common Stock (PURR) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hyperliquid Strategies Inc Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Hyperliquid Strategies Inc Common Stock trades at $11.3 (market cap $2.24B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.66 (market cap $2.27B). The key difference: Hyperliquid Strategies Inc Common Stock and SELLAS Life Sciences Group Inc. Common Stock are close in size by market cap, and Hyperliquid Strategies Inc Common Stock is more actively traded (14,135,020 versus 4,179,659). Which is the better fit depends on your goals.
| PURR | SLS | |
|---|---|---|
Market Cap | $2.24B | $2.27B |
Volume | 14,135,020 | 4,179,659 |
Sector | Financials | Health |
52-Week High | $14.09 | $15.46 |
52-Week Low | $3.10 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $2.10B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies is a digital asset treasury company focused on managing a treasury of HYPE tokens, the native digital assets of the Hyperliquid Layer-1 blockchain.
Read more on PURR →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
